Korean J Urol.  2014 Oct;55(10):670-676. 10.4111/kju.2014.55.10.670.

Role of Urinary Levels of Endothelin-1, Monocyte Chemotactic Peptide-1, and N-Acetyl Glucosaminidase in Predicting the Severity of Obstruction in Hydronephrotic Neonates

Affiliations
  • 1Antimicrobial Resistant Nosocomial Infection Research Center, Mazandaran University of Medical Sciences, Sari, Iran. hamidmjaafari@yahoo.com
  • 2Molecular and Cell Biology Research Center, Hemoglubinopathy Institute, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • 3Department of Radiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

Abstract

PURPOSE
Antenatal hydronephrosis (AH) is found in 0.5%-1% of neonates. The aim of the study was to assess the urinary concentrations of 3 biomarkers, endothelin-1 (ET-1), monocyte chemotactic peptide-1 (MCP-1), and N-acetyl-glucosaminidase (NAG) in severely hydronephrotic neonates.
MATERIALS AND METHODS
Neonates with a history of prenatal hydronephrosis were enrolled in the prospective study in 2 groups. Group 1 included neonates with severe forms of obstruction requiring surgical intervention and group 2 included neonates with milder forms of obstruction without any functional impairment. Fresh voided urinary levels of ET-1, MCP-1, and NAG were measured and their ratios to urinary Cr were calculated.
RESULTS
Fourty-two neonates were enrolled into the 2 groups: group 1, 24 patients (21 male, 3 female); group 2, 18 neonates (16 male, 2 female). There were no statistically significant differences between urinary ET-1, NAG, MCP-1 values, and ET-1/Cr and NAG/Cr ratios in groups 1 and 2. The urinary MCP-1/Cr ratio was significantly higher in group 1 than in group 2. For comparison of groups 1 and 2, the cut-off values were measured as 0.5709 ng/mg (sensitivity, 75%; specificity, 67%; positive predictive value [PPV], 71%; negative predictive value [NPV], 71%), 0.927 ng/mg (sensitivity, 77%; specificity, 72%; PPV, 77%; NPV, 72%), and 1.1913 IU/mg (sensitivity, 62%; specificity, 67%; PPV, 68%; NPV, 60%) for ET-1/Cr, MCP-1/Cr, and NAG/Cr ratios, respectively.
CONCLUSIONS
The urinary MCP-1/Cr ratio is significantly elevated in neonates with severe obstruction requiring surgical intervention. Based upon these results, urinary MCP-1/Cr may be useful in identification of severe obstructive hydronephrosis in neonates.

Keyword

Acetylglucosaminidase; Endothelin-1; Hydronephrosis; MCP1 protein; Neonate

MeSH Terms

Acetylglucosaminidase/*urine
Biological Markers/urine
Chemokine CCL2/*urine
Endothelin-1/*urine
Female
Humans
Hydronephrosis/*congenital/etiology/surgery/ultrasonography
Infant, Newborn
Male
Predictive Value of Tests
Prospective Studies
Sensitivity and Specificity
Ureteral Obstruction/complications/*diagnosis/surgery
Acetylglucosaminidase
Biological Markers
Chemokine CCL2
Endothelin-1

Figure

  • FIG. 1 Receiver operating characteristic (ROC) curve to detect severe obstruction (differentiate group 1 from group 2). (A) For endothelin-1 to creatinine ratio (ET-1/Cr), area under the curve (AUC)=0.657 (standard error [SE], 0.094; 95% confidence interval [CI], 0.473-0.841). (B) For monocyte chemotactic peptide-1 to creatinine ratio (MCP-1/Cr) ratio, AUC=0.732 (SE, 0.084; 95% CI, 0.568-0.896). (C) For N-acetyl-beta-D-glucosaminidase to creatinine ratio (NAG/Cr), AUC=0.627 (SE, 0.088; 95% CI, 0.500-0.844).


Reference

1. Coplen DE. The Society for Fetal Urology consensus statement on the evaluation and management of antenatal hydronephrosis: Nguyen HT, Herndon CDA, Cooper C, et al (Children's Hosp, Boston, MA; Children's Hosp of Alabama, Birmingham; Univ of Iowa Med Ctr, Iowa City; et al) J Pediatr Urol 6:212-231, 2010. Yearb Urol. 2010; 2010:209.
2. Yamacake KG, Nguyen HT. Current management of antenatal hydronephrosis. Pediatr Nephrol. 2013; 28:237–243. PMID: 22836304.
Article
3. Mohammadjafari H, Alam A, Kosarian M, Mousavi SA, Kosarian S. Vesicoureteral reflux in neonates with hydronephrosis; role of imaging tools. Iran J Pediatr. 2009; 19:347–353.
4. Vazirian S, Mohammadjafari H, Mohammadjafari R. Postnatal management of prenatal hydronephrosis. J Clin Excell. 2013; 1:63–82.
5. Ucero AC, Benito-Martin A, Izquierdo MC, Sanchez-Nino MD, Sanz AB, Ramos AM, et al. Unilateral ureteral obstruction: beyond obstruction. Int Urol Nephrol. 2014; 46:765–776. PMID: 24072452.
Article
6. Cao YS, Yu DX, Cai Y, Chao M. Diagnosis and treatment of ureteropelvic junction obstruction in children. J Appl Clin Pediatr. 2007; 22:825.
7. Klein J, Gonzalez J, Miravete M, Caubet C, Chaaya R, Decramer S, et al. Congenital ureteropelvic junction obstruction: human disease and animal models. Int J Exp Pathol. 2011; 92:168–192. PMID: 20681980.
Article
8. Abedi SM, Mohammadjafari H, Hosseinimehr SJ, Mardanshahi A, Shahhosseini R. Imaging of renal cortex in nuclear medicine. J Clin Excell. 2014; 2:50–69.
9. Mohammadjafari H, Rafiei A, Abedi M, Aalaee A, Mirabi AM, Abedi E. Urinary neutrophil-gelatinase associated lipocalin is a more prognostic biomarker to distinguish antenatal hydronephrosis in neonates. Res Mol Med. 2013; 1:10–16.
Article
10. Trnka P, Hiatt MJ, Tarantal AF, Matsell DG. Congenital urinary tract obstruction: defining markers of developmental kidney injury. Pediatr Res. 2012; 72:446–454. PMID: 22902433.
Article
11. Chevalier RL. Obstructive nephropathy: towards biomarker discovery and gene therapy. Nat Clin Pract Nephrol. 2006; 2:157–168. PMID: 16932414.
Article
12. Mohammadjafari H, Rafiei A, Abedi M, Aalaee A, Abedi E. The role of urinary TIMP1 and MMP9 levels in predicting vesicoureteral reflux in neonates with antenatal hydronephrosis. Pediatr Nephrol. 2014; 29:871–878. PMID: 24389602.
Article
13. Sharifian M, Ahmadi M, Karimi A, Zand RE, Moghadar R, Ahmadi R, et al. Urinary endothellin-1 level in children with pyelonephritis and hydronephrosis. Saudi J Kidney Dis Transpl. 2013; 24:731–736. PMID: 23816722.
Article
14. Pollock D. Endothelin and the kidney. In : Battistini B, Warner TD, editors. Endothelin and its inhibitors. New York: Springer;2001. p. 477–501.
15. Grandaliano G, Gesualdo L, Bartoli F, Ranieri E, Monno R, Leggio A, et al. MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy. Kidney Int. 2000; 58:182–192. PMID: 10886563.
Article
16. Stephan M, Conrad S, Eggert T, Heuer R, Fernandez S, Huland H. Urinary concentration and tissue messenger RNA expression of monocyte chemoattractant protein-1 as an indicator of the degree of hydronephrotic atrophy in partial ureteral obstruction. J Urol. 2002; 167:1497–1502. PMID: 11832777.
Article
17. Skalova S, Rejtar P, Kutilek S. Increased urinary N-acetyl-beta-D-glucosaminidase activity in children with hydronephrosis. Int Braz J Urol. 2007; 33:80–83. PMID: 17335604.
Article
18. Ma H, Fang Y, Tian WC, Qian K, Li J, Yang JJ, et al. Clinical value of renal dynamic imaging and urinary N-acetyl-β-D-glucosaminidase, apoptosis DNA fragment detection in evaluating damage degree of hydronephrotic kidneys in children with hydronephrosis. J Appl Clin Pediatr. 2009; 16:036.
19. Csathy L, Pocsi I. Urinary N-acetyl-beta-D-glucosaminidase determination in newborns and children: methods and diagnostic applications. Eur J Clin Chem Clin Biochem. 1995; 33:575–587. PMID: 8611667.
20. Chertin B, Pollack A, Koulikov D, Rabinowitz R, Hain D, Hadas-Halpren I, et al. Conservative treatment of ureteropelvic junction obstruction in children with antenatal diagnosis of hydronephrosis: lessons learned after 16 years of follow-up. Eur Urol. 2006; 49:734–738. PMID: 16504374.
Article
21. Tombesi MM, Alconcher LF. Short-term outcome of mild isolated antenatal hydronephrosis conservatively managed. J Pediatr Urol. 2012; 8:129–133. PMID: 21798811.
Article
22. Chevalier RL, Thornhill BA, Forbes MS, Kiley SC. Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy. Pediatr Nephrol. 2010; 25:687–697. PMID: 19844747.
Article
23. Bartoli F, Penza R, Aceto G, Niglio F, D'ddato O, Pastore V, et al. Urinary epidermal growth factor, monocyte chemotactic protein-1, and β2-microglobulin in children with ureteropelvic junction obstruction. J Pediatr Surg. 2011; 46:530–536. PMID: 21376205.
Article
24. Taranta-Janusz K, Wasilewska A, Debek W, Waszkiewicz-Stojda M. Urinary cytokine profiles in unilateral congenital hydronephrosis. Pediatr Nephrol. 2012; 27:2107–2113. PMID: 22744767.
Article
25. Madsen MG, Norregaard R, Palmfeldt J, Olsen LH, Frokiar J, Jorgensen TM. Epidermal growth factor and monocyte chemotactic peptide-1: potential biomarkers of urinary tract obstruction in children with hydronephrosis. J Pediatr Urol. 2013; 9(6 Pt A):838–845. PMID: 23228281.
Article
26. Knerr I, Nyul Z, Miller J, Rosch W, Dotsch J, Repp R, et al. Increased endothelin-1 and decreased adrenomedullin gene expression in the stenotic tissue of congenital pelvi-ureteric junction obstruction in children. BJU Int. 2001; 87:667–671. PMID: 11350409.
Article
Full Text Links
  • KJU
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr